Skip to content
healthcare.dev

Irinotecan Hydrochloride

NDC 60505-6272, Irinotecan Hydrochloride, injection, solution, from Apotex Corp..

Product NDC
60505-6272
Status
Listed
Labeler
Apotex Corp.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203380
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6272 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRINOTECAN HYDROCHLORIDE20 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
60505-6272-1605056272011 VIAL, SINGLE-USE in 1 CARTON (60505-6272-1) / 5 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8fe98987-e526-4729-a8f4-c7230f424108
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=60505-6272

Use it

Look up 60505-6272 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6272 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-6272. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.